![](/img/cover-not-exists.png)
PDB20 COMPARISON OF THE COST TO REACH A1C TARGETS IN PATIENTS WITH TYPE-2 DIABETES MELLITUS ON ORAL ANTIDIABETIC AGENTS AND EITHER BIPHASIC INSULIN ASPART 70/30 OR INSULIN GLARGINE
D Cobden, E Allen, M BottemanVolume:
8
Year:
2005
Language:
english
DOI:
10.1016/s1098-3015(10)62953-1
File:
PDF, 68 KB
english, 2005